{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:37:56Z","timestamp":1793410676098,"version":"4.5.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046526"],"award-info":[{"award-number":["R01DA046526"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA052937"],"award-info":[{"award-number":["R01DA052937"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03DA045881"],"award-info":[{"award-number":["R03DA045881"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03DA054098"],"award-info":[{"award-number":["R03DA054098"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA044479"],"award-info":[{"award-number":["R21DA044479"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA049130"],"award-info":[{"award-number":["R21DA049130"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Emergent harms presented by the co-use of opioids and methamphetamine highlight the broader public health challenge of preventing and treating opioid and stimulant co-use. Development of effective therapeutics requires an understanding of the physiological mechanisms that may be driving co-use patterns, specifically the underlying neurobiology of co-use and how they may facilitate (or be leveraged to prevent) continued use patterns. This narrative review summarizes largely preclinical data that demonstrate clinically-meaningful relationships between the dopamine and opioid systems with direct implications for opioid and stimulant co-use. Synthesized conclusions of this body of research include evidence that changes in the dopamine system occur only once physical dependence to opioids develops, that the chronicity of opioid exposure is associated with the severity of changes, and that withdrawal leaves the organism in a state of substantive dopamine deficit that persists long after the somatic or observed signs of opioid withdrawal appear to have resolved. Evidence also suggests that dopamine supersensitivity develops soon after opioid abstinence and results in increased response to dopamine agonists that increases in magnitude as the abstinence period continues and is evident several weeks into protracted withdrawal. Mechanistically, this supersensitivity appears to be mediated by changes in the sensitivity, not quantity, of dopamine D2 receptors. Here we propose a neural circuit mechanism unique to withdrawal from opioid use with implications for increased stimulant sensitivity in previously stimulant-na\u00efve or inexperienced populations. These hypothesized effects collectively delineate a mechanism by which stimulants would be uniquely reinforcing to persons with opioid physical dependence, would contribute to the acute opioid withdrawal syndrome, and could manifest subjectively as craving and\/or motivation to use that could prompt opioid relapse during acute and protracted withdrawal. Preclinical research is needed to directly test these hypothesized mechanisms. Human laboratory and clinical trial research is needed to explore these clinical predictions and to advance the goal of developing treatments for opioid-stimulant co-use and\/or opioid relapse prevention and withdrawal remediation.<\/jats:p>","DOI":"10.3389\/fpsyt.2022.835816","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:40:00Z","timestamp":1650001200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse"],"prefix":"10.3389","volume":"13","author":[{"given":"Justin C.","family":"Strickland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1186\/s13011-021-00350-5","article-title":"'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America","volume":"16","author":"Fischer","year":"2021","journal-title":"Subst Abuse Treat Prev Policy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction."},{"key":"B4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"B5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am J Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"108750","DOI":"10.1016\/j.drugalcdep.2021.108750","article-title":"The continued rise of methamphetamine use among people who use heroin in the united states","volume":"225","author":"Strickland","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107592","DOI":"10.1016\/j.drugalcdep.2019.107592","article-title":"A nationally representative analysis of \u201ctwin epidemics\u201d: rising rates of methamphetamine use among persons who use opioids","volume":"204","author":"Strickland","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B8","doi-asserted-by":"publisher","first-page":"108089","DOI":"10.1016\/j.drugalcdep.2020.108089","article-title":"Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018","volume":"213","author":"Palamar","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 States, July-December 2017 to January-June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamapediatrics.2020.5035","article-title":"Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999-2018","volume":"175","author":"Lim","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2020003491","DOI":"10.1542\/peds.2020-003491","article-title":"Suspected nonfatal drug-related overdoses among youth in the US: 2016-2019","volume":"147","author":"Roehler","year":"2021","journal-title":"Pediatrics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"108384","DOI":"10.1016\/j.drugalcdep.2020.108384","article-title":"Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: state-level differences and the role of opioids","volume":"218","author":"Cano","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the us by sex and race and ethnicity","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/MLR.0000000000001460","article-title":"Service involvement across multiple sectors among people who use opioids, methamphetamine, or both, United States-2015-2018","volume":"59","author":"Howell","year":"2021","journal-title":"Med Care."},{"key":"B15","doi-asserted-by":"publisher","first-page":"108162","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00005053-198803000-00006","article-title":"Antecedents and consequences of cocaine abuse among opioid addicts. A 25-year follow-up","volume":"176","author":"Kosten","year":"1988","journal-title":"J Nerv Ment Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use","volume":"85","author":"Hartel","year":"1995","journal-title":"Am J Public Health."},{"key":"B18","first-page":"40","article-title":"Heroin and cocaine co-use in a group of injection drug users in Montr\u00e9al","volume":"29","author":"Leri","year":"2004","journal-title":"J Psychiatry Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0376-8716(91)90083-B","article-title":"Cocaine abuse among heroin addicts in Spain","volume":"27","author":"Torrens","year":"1991","journal-title":"Drug Alcohol Depend."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction."},{"key":"B21","doi-asserted-by":"publisher","first-page":"108193","DOI":"10.1016\/j.drugalcdep.2020.108193","article-title":"A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders","volume":"216","author":"Chan","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0740-5472(91)90040-H","article-title":"Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions","volume":"8","author":"Condelli","year":"1991","journal-title":"J Subst Abuse Treat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000500542","article-title":"Concomitant heroin and cocaine use among opioid-dependent patients during methadone, buprenorphine or morphine opioid agonist therapy","volume":"25","author":"Gastberger","year":"2019","journal-title":"Eur Addict Res."},{"key":"B24","first-page":"328","article-title":"Cocaine and heroin use by methadone maintenance patients","volume":"95","author":"Ball","year":"1989","journal-title":"NIDA Res Monogr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1300\/J251v06n02_07","article-title":"Cocaine use in persons on methadone maintenance","volume":"6","author":"Hanbury","year":"1986","journal-title":"Adv Alcohol Subst Abuse."},{"key":"B26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/02791072.1994.10472260","article-title":"Cocaine abuse among methadone maintenance patients: are there effective treatment strategies?","volume":"26","author":"Rawson","year":"1994","journal-title":"J Psychoactive Drugs."},{"key":"B27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.1996.01830050045007","article-title":"Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy","volume":"53","author":"Silverman","year":"1996","journal-title":"Arch Gen Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","article-title":"A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients","volume":"40","author":"Margolin","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"B30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-6147(92)90062-B","article-title":"Neurobiology of opiate abuse","volume":"13","author":"Di Chiara","year":"1992","journal-title":"Trends Pharmacol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement","volume":"87","author":"Koob","year":"2020","journal-title":"Biol Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF02246140","article-title":"Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats","volume":"120","author":"Wise","year":"1995","journal-title":"Psychopharmacology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/syn.890210207","article-title":"Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration","volume":"21","author":"Wise","year":"1995","journal-title":"Synapse."},{"key":"B36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.conb.2013.01.026","article-title":"Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways)","volume":"23","author":"Smith","year":"2013","journal-title":"Curr Opin Neurobiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nn.3369","article-title":"Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use","volume":"16","author":"Bock","year":"2013","journal-title":"Nat Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1188472","article-title":"Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward","volume":"330","author":"Lobo","year":"2010","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1124\/pr.116.012484","article-title":"The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis","volume":"68","author":"Scofield","year":"2016","journal-title":"Pharmacol Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu Rev Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1523\/JNEUROSCI.2582-06.2006","article-title":"Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia","volume":"26","author":"Nadjar","year":"2006","journal-title":"J Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e4770","DOI":"10.1371\/journal.pone.0004770","article-title":"Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice","volume":"4","author":"Matamales","year":"2009","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.biopsych.2020.12.004","article-title":"Heroin seeking and extinction from seeking activate matrix metalloproteinases at synapses on distinct subpopulations of accumbens cells","volume":"89","author":"Chioma","year":"2021","journal-title":"Biol Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.expneurol.2006.05.023","article-title":"Contingent and non-contingent effects of heroin on mu-opioid receptor-containing ventral tegmental area GABA neurons","volume":"202","author":"Steffensen","year":"2006","journal-title":"Exp Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00427441","article-title":"Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats","volume":"84","author":"Pettit","year":"1984","journal-title":"Psychopharmacology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2003.08.065","article-title":"Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine","volume":"479","author":"Kahlig","year":"2003","journal-title":"Eur J Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"108763","DOI":"10.1016\/j.neuropharm.2021.108763","article-title":"The rostromedial tegmental (RMTg)\u201cbrake\u201d on dopamine and behavior: a decade of progress but also much unfinished work","volume":"198","author":"Jhou","year":"2021","journal-title":"Neuropharmacology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1523\/JNEUROSCI.1847-20.2021","article-title":"Synaptic adaptations at the rostromedial tegmental nucleus underlie individual differences in cocaine avoidance behavior","volume":"41","author":"Parrilla-Carrero","year":"2021","journal-title":"J Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1523\/JNEUROSCI.3634-12.2013","article-title":"Xu S-p, Wang H, Burnham NW, et al. Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways","volume":"33","author":"Jhou","year":"2013","journal-title":"J Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron."},{"key":"B52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1113\/jphysiol.1954.sp005064","article-title":"The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs","volume":"123","author":"Vogt","year":"1954","journal-title":"J Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0031-6989(79)80051-X","article-title":"Dose-time motility effects of morphine and methadone in naive or morphinized rats","volume":"11","author":"Babbini","year":"1979","journal-title":"Pharmacol Res Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0304-3940(79)96149-4","article-title":"The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat","volume":"14","author":"Joyce","year":"1979","journal-title":"Neurosci Lett."},{"key":"B55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00408180","article-title":"Tolerance to and physical dependence on morphine in rats","volume":"4","author":"Martin","year":"1963","journal-title":"Psychopharmacologia."},{"key":"B56","first-page":"848","article-title":"Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat","volume":"207","author":"Vasko","year":"1978","journal-title":"J Pharmacol Exp Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0361-9230(83)90163-6","article-title":"Circling from intracranial morphine applied to the ventral tegmental area in rats","volume":"11","author":"Holmes","year":"1983","journal-title":"Brain Res Bull."},{"key":"B59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0006-8993(85)91380-0","article-title":"Contralateral circling induced by tegmental morphine: anatomical localization, pharmacological specificity, and phenomenology","volume":"326","author":"Holmes","year":"1985","journal-title":"Brain Res."},{"key":"B60","first-page":"229","article-title":"Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity","volume":"227","author":"Kalivas","year":"1983","journal-title":"J Pharmacol Exp Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1124\/jpet.119.258004","article-title":"Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence","volume":"371","author":"Dunn","year":"2019","journal-title":"J Pharmacol Exp Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0091-3057(76)90238-0","article-title":"Dopaminergic involvement in withdrawal hypothermia and thermoregulatory behavior in morphine dependent rats","volume":"4","author":"Cox","year":"1976","journal-title":"Pharmacol Biochem Behav."},{"key":"B63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0014-2999(91)90214-B","article-title":"Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats","volume":"193","author":"Acquas","year":"1991","journal-title":"Eur J Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0014-2999(77)90070-X","article-title":"Changes in striatal dopamine metabolism during precipitated morphine withdrawal","volume":"44","author":"Gramsch","year":"1977","journal-title":"Eur J Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0014-2999(69)90110-1","article-title":"Effects of morphine intoxication on brain catecholamine neurons","volume":"5","author":"Gunne","year":"1969","journal-title":"Eur J Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0006-8993(91)91724-F","article-title":"Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment","volume":"566","author":"Pothos","year":"1991","journal-title":"Brain Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(92)90706-A","article-title":"Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats","volume":"221","author":"Rossetti","year":"1992","journal-title":"Eur J Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000054521","article-title":"Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal","volume":"71","author":"Fuertes","year":"2000","journal-title":"Neuroendocrinology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF00408181","article-title":"The effect of addiction to and abstinence from morphine on rat tissue catecholamine and serotonin levels","volume":"4","author":"Sloan","year":"1963","journal-title":"Psychopharmacologia."},{"key":"B70","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1460-9568.2003.02435.x","article-title":"Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy","volume":"17","author":"Spiga","year":"2003","journal-title":"Eur J Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/j.1471-4159.1976.tb02645.x","article-title":"Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal","volume":"27","author":"Puri","year":"1976","journal-title":"J Neurochem."},{"key":"B72","first-page":"503","article-title":"Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions","volume":"197","author":"Iwamoto","year":"1976","journal-title":"J Pharmacol Exp Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1749-6632.1992.tb26016.x","article-title":"Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence","volume":"654","author":"Rossetti","year":"1992","journal-title":"Ann N Y Acad Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41398-021-01548-8","article-title":"Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men","volume":"11","author":"Shokri-Kojori","year":"2021","journal-title":"Transl Psychiatry."},{"key":"B75","first-page":"781","article-title":"Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats","volume":"272","author":"Diana","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/j.1471-4159.1992.tb10033.x","article-title":"Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence","volume":"58","author":"Acquas","year":"1992","journal-title":"J Neurochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1046\/j.1460-9568.1999.00488.x","article-title":"Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal","volume":"11","author":"Diana","year":"1999","journal-title":"Eur J Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1460-9568.1999.00462.x","article-title":"Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum","volume":"11","author":"Georges","year":"1999","journal-title":"Eur J Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1460-9568.2001.01455.x","article-title":"The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice","volume":"13","author":"Dockstader","year":"2001","journal-title":"Eur J Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","article-title":"Deficits in dopamine D receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction","volume":"71","author":"Martinez","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0893-133X(96)00184-4","article-title":"Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal","volume":"16","author":"Wang","year":"1997","journal-title":"Neuropsychopharmacology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0091-3057(95)02225-2","article-title":"Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole","volume":"54","author":"Piepponen","year":"1996","journal-title":"Pharmacol Biochem Behav."},{"key":"B83","first-page":"531","article-title":"Behavioral activation induced by D-like receptor stimulation during opiate withdrawal","volume":"294","author":"Druhan","year":"2000","journal-title":"J Pharmacol Exp Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00508644","article-title":"Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant\/dependent rats","volume":"299","author":"Schulz","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF02244606","article-title":"Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats","volume":"100","author":"Wise","year":"1990","journal-title":"Psychopharmacology."},{"key":"B86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0006-8993(93)91519-X","article-title":"Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats","volume":"607","author":"Reddy","year":"1993","journal-title":"Brain Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF00404736","article-title":"Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs","volume":"16","author":"Fog","year":"1970","journal-title":"Psychopharmacologia."},{"key":"B88","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.9.1440","article-title":"Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry."},{"key":"B89","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/syn.10137","article-title":"Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study","volume":"46","author":"Volkow","year":"2002","journal-title":"Synapse."},{"key":"B90","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"74","author":"Ashok","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"B91","first-page":"523","article-title":"Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy?","volume":"22","author":"Sicuteri","year":"1980","journal-title":"Adv Biochem Psychopharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0893-133X(01)00293-7","article-title":"Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization","volume":"26","author":"De Vries","year":"2002","journal-title":"Neuropsychopharmacology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-2999(77)90298-9","article-title":"Changes in sensitivity to operant effects of dopaminergic and cholinergic agents following morphine withdrawal in rats","volume":"42","author":"Glick","year":"1977","journal-title":"Eur J Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0014-2999(76)90199-0","article-title":"Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions","volume":"38","author":"Iwamoto","year":"1976","journal-title":"Eur J Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1476-5381.1980.tb09773.x","article-title":"Morphine dependence and dopaminergic activity: tests of circling responses in rats with unilateral nigral lesions","volume":"70","author":"Halliwell","year":"1980","journal-title":"Br J Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/260159a0","article-title":"Changes in sensitivity of morphine-induced circling behaviour after chronic treatment and persistence after withdrawal in rats","volume":"260","author":"Glick","year":"1976","journal-title":"Nature."},{"key":"B98","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00401783","article-title":"Morphine-withdrawal aggression: sensitization by amphetamines","volume":"22","author":"Lal","year":"1971","journal-title":"Psychopharmacologia."},{"key":"B99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00421218","article-title":"Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinence","volume":"34","author":"Gianutsos","year":"1974","journal-title":"Psychopharmacologia."},{"key":"B100","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1037\/1064-1297.16.5.429","article-title":"Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study","volume":"16","author":"Bieber","year":"2008","journal-title":"Exp Clin Psychopharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/jnr.24643","article-title":"Retrospectively assessed subjective effects of initial opioid use differ between opioid misusers with opioid use disorder (OUD) and those who never progressed to OUD: data from a pilot and a replication sample","volume":"100","author":"Agrawal","year":"2020","journal-title":"J Neurosci Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1901\/jeab.1994.61-169","article-title":"Human d-amphetamine drug discrimination: methamphetamine and hydromorphone","volume":"61","author":"Lamb","year":"1994","journal-title":"J Exp Anal Behav."},{"key":"B103","first-page":"524","article-title":"Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","volume":"279","author":"Walsh","year":"1996","journal-title":"J Pharmacol Exp Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"109145","DOI":"10.1016\/j.drugalcdep.2021.109145","article-title":"A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs","volume":"229","author":"Hansen","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B105","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/ADM.0000000000000669","article-title":"\u201cLike Yin and Yang\u201d: perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities","volume":"15","author":"Baker","year":"2021","journal-title":"J Addict Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-020-00360-9","article-title":"Motivations for crystal methamphetamine-opioid co-injection\/co-use amongst community-recruited people who inject drugs: a qualitative study","volume":"17","author":"Palmer","year":"2020","journal-title":"Harm Reduct J."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0024-3205(90)90366-Y","article-title":"Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal","volume":"47","author":"Kosten","year":"1990","journal-title":"Life Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/13556210500123514","article-title":"Low efficacy of non-opioid drugs in opioid withdrawal symptoms","volume":"10","author":"Hermann","year":"2005","journal-title":"Addict Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/00952999409109183","article-title":"Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance","volume":"20","author":"Stine","year":"1994","journal-title":"Am J Drug Alcohol Abuse."},{"key":"B110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF02246276","article-title":"Enhancement of cocaine's abuse liability in methadone maintenance patients","volume":"123","author":"Preston","year":"1996","journal-title":"Psychopharmacology."},{"key":"B111","first-page":"38","article-title":"Effects of single and multiple intravenous cocaine injections in humans maintained on methadone","volume":"275","author":"Foltin","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00004714-199402000-00003","article-title":"Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men","volume":"14","author":"Teoh","year":"1994","journal-title":"J Clin Psychopharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/npp.2016.160","article-title":"The direct and indirect pathways of the nucleus accumbens are not what you think","volume":"42","author":"Kupchik","year":"2017","journal-title":"Neuropsychopharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"12764","DOI":"10.1073\/pnas.1210797109","article-title":"Pathway-specific control of reward learning and its flexibility via selective dopamine receptors in the nucleus accumbens","volume":"109","author":"Yawata","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/nn.4068","article-title":"Coding the direct\/indirect pathways by D1 and D2 receptors is not valid for accumbens projections","volume":"18","author":"Kupchik","year":"2015","journal-title":"Nat Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1523\/JNEUROSCI.2822-18.2018","article-title":"Ventral pallidum is the primary target for accumbens d1 projections driving cocaine seeking","volume":"39","author":"Pardo-Garcia","year":"2019","journal-title":"J Neurosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1523\/JNEUROSCI.0791-18.2018","article-title":"Drug Refraining and seeking potentiate synapses on distinct populations of accumbens medium spiny neurons","volume":"38","author":"Roberts-Wolfe","year":"2018","journal-title":"J Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1523\/JNEUROSCI.2369-11.2011","article-title":"Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: in vivo optical microprobe [Ca2+]i imaging","volume":"31","author":"Luo","year":"2011","journal-title":"J Neurosci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1523\/JNEUROSCI.2659-16.2016","article-title":"Loss of plasticity in the D2-accumbens pallidal pathway promotes cocaine seeking","volume":"37","author":"Heinsbroek","year":"2017","journal-title":"J Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2016.04.031","article-title":"Dopamine Regulation of lateral inhibition between striatal neurons gates the stimulant actions of cocaine","volume":"90","author":"Dobbs","year":"2016","journal-title":"Neuron."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science."},{"key":"B123","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1081\/RRS-200029981","article-title":"Dopamine receptor signaling","volume":"24","author":"Neve","year":"2004","journal-title":"J Recept Signal Transduct Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41467-018-03272-2","article-title":"Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum","volume":"9","author":"Gallo","year":"2018","journal-title":"Nat Commun."},{"key":"B126","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/B978-008045046-9.01240-7","article-title":"GABA synthesis and metabolism","author":"Behar","year":"2009","journal-title":"Encyc Neurosci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-8993(85)90331-2","article-title":"Evidence for the coexistence of glutamate decarboxylase and Met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum","volume":"325","author":"Zahm","year":"1985","journal-title":"Brain Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0306-4522(93)90048-K","article-title":"GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area","volume":"57","author":"Kalivas","year":"1993","journal-title":"Neuroscience."},{"key":"B129","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0306-4522(97)00327-8","article-title":"Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens","volume":"82","author":"Lu","year":"1998","journal-title":"Neuroscience."},{"key":"B130","first-page":"231","article-title":"Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain","volume":"5","author":"Meador-Woodruff","year":"1991","journal-title":"Neuropsychopharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0006-8993(93)90303-5","article-title":"Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons","volume":"621","author":"Lester","year":"1993","journal-title":"Brain Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"36625","DOI":"10.1074\/jbc.M110.159954","article-title":"The dopamine D1-D2 receptor heteromer localizes in dynorphin\/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia","volume":"285","author":"Perreault","year":"2010","journal-title":"J Biol Chem."},{"key":"B133","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnana.2011.00031","article-title":"The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia","volume":"5","author":"Perreault","year":"2011","journal-title":"Front Neuroanat."},{"key":"B134","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/287022a0","article-title":"Enkephalin blocks inhibitory pathways in the vertebrate CNS","volume":"287","author":"Nicoll","year":"1980","journal-title":"Nature."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1523\/JNEUROSCI.04-06-01626.1984","article-title":"The ventral pallidal projection to the mediodorsal thalamus: a study with fluorescent retrograde tracers and immunohistofluorescence","volume":"4","author":"Young WS","year":"1984","journal-title":"J Neurosci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0306-4522(97)00573-3","article-title":"GABAergic and cholinergic basal forebrain and preoptic-anterior hypothalamic projections to the mediodorsal nucleus of the thalamus in the cat","volume":"85","author":"Gritti","year":"1998","journal-title":"Neuroscience."},{"key":"B137","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1365-2869.2001.00246.x","article-title":"The synchronizing influence of substantia innominata on the thalamus of the cat","volume":"10","author":"Mariotti","year":"2001","journal-title":"J Sleep Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2007.02.008","article-title":"Feeding and systemic D-amphetamine increase extracellular acetylcholine in the medial thalamus: a possible reward enabling function","volume":"416","author":"Rada","year":"2007","journal-title":"Neurosci Lett."},{"key":"B139","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0306-4522(93)90115-V","article-title":"Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents","volume":"57","author":"Groenewegen","year":"1993","journal-title":"Neuroscience."},{"key":"B140","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1523\/JNEUROSCI.0968-05.2005","article-title":"The primate thalamus is a key target for brain dopamine","volume":"25","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2005","journal-title":"J Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0306-4522(92)90430-A","article-title":"Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum","volume":"50","author":"Klitenick","year":"1992","journal-title":"Neuroscience."},{"key":"B142","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0924-8196(97)80008-5","article-title":"Chapter VI dopamine systems in the primate brain","volume":"13","author":"Lewis","year":"1997","journal-title":"Handb Chem Neuroanat."},{"key":"B143","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/brain\/awp328","article-title":"The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease","volume":"133","author":"Grealish","year":"2010","journal-title":"Brain."},{"key":"B144","doi-asserted-by":"publisher","first-page":"20170028","DOI":"10.1098\/rstb.2017.0028","article-title":"The thalamus in drug addiction: from rodents to humans","volume":"373","author":"Huang","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e12716","DOI":"10.1111\/adb.12716","article-title":"The influence of sex and estrous cyclicity on cocaine and remifentanil demand in rats","volume":"25","author":"Lacy","year":"2020","journal-title":"Addict Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1901\/jeab.2011.95-75","article-title":"Effects of daily morphine administration and deprivation on choice and demand for remifentanil and cocaine in rhesus monkeys","volume":"95","author":"Wade-Galuska","year":"2011","journal-title":"J Exp Anal Behav."},{"key":"B147","doi-asserted-by":"publisher","first-page":"116952","DOI":"10.1016\/j.jns.2020.116952","article-title":"Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors","volume":"415","author":"Antons","year":"2020","journal-title":"J Neurol Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"109057","DOI":"10.1016\/j.drugalcdep.2021.109057","article-title":"Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS","volume":"229","author":"Boyett","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B149","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/35084134","article-title":"Incubation of cocaine craving after withdrawal","volume":"412","author":"Grimm","year":"2001","journal-title":"Nature."},{"key":"B150","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1570159X13666160512150918","article-title":"Common neurogenetic diagnosis and meso-limbic manipulation of hypodopaminergic function in Reward Deficiency Syndrome (RDS): changing the recovery landscape","volume":"15","author":"Blum","year":"2017","journal-title":"Curr Neuropharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"116733","DOI":"10.1016\/j.jns.2020.116733","article-title":"Molecular neurological correlates of endorphinergic\/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS)","volume":"411","author":"Blum","year":"2020","journal-title":"J Neurol Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"117137","DOI":"10.1016\/j.jns.2020.117137","article-title":"Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?","volume":"418","author":"Gold","year":"2020","journal-title":"J Neurol Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"107609","DOI":"10.1016\/j.neuropharm.2019.04.015","article-title":"Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine","volume":"158","author":"Jordan","year":"2019","journal-title":"Neuropharmacology."},{"key":"B154","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.2174\/138161281940131209142843","article-title":"Agonist replacement for stimulant dependence: a review of clinical research","volume":"19","author":"Stoops","year":"2013","journal-title":"Curr Pharm Des."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.835816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:21:21Z","timestamp":1675308081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.835816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":154,"alternative-id":["10.3389\/fpsyt.2022.835816"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.835816","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"835816"}}